The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases

Abstract

BackgroundThere are a lack of reliable data on the epidemiology and associated burden and costs of asthma. We sought to provide the first UK-wide estimates of the epidemiology, healthcare utilisation and costs of asthma.MethodsWe obtained and analysed asthma-relevant data from 27 datasets: these comprised national health surveys for 2010–11, and routine administrative, health and social care datasets for 2011–12; 2011–12 costs were estimated in pounds sterling using economic modelling.ResultsThe prevalence of asthma depended on the definition and data source used. The UK lifetime prevalence of patient-reported symptoms suggestive of asthma was 29.5 % (95 % CI, 27.7–31.3; n = 18.5 million (m) people) and 15.6 % (14.3–16.9, n = 9.8 m) for patient-reported clinician-diagnosed asthma. The annual prevalence of patient-reported clinician-diagnosed-and-treated asthma was 9.6 % (8.9–10.3, n = 6.0 m) and of clinician-reported, diagnosed-and-treated asthma 5.7 % (5.7–5.7; n = 3.6 m). Asthma resulted in at least 6.3 m primary care consultations, 93,000 hospital in-patient episodes, 1800 intensive-care unit episodes and 36,800 disability living allowance claims. The costs of asthma were estimated at least £1.1 billion: 74 % of these costs were for provision of primary care services (60 % prescribing, 14 % consultations), 13 % for disability claims, and 12 % for hospital care. There were 1160 asthma deaths.ConclusionsAsthma is very common and is responsible for considerable morbidity, healthcare utilisation and financial costs to the UK public sector. Greater policy focus on primary care provision is needed to reduce the risk of asthma exacerbations, hospitalisations and deaths, and reduce costs.Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-016-0657-8) contains supplementary material, which is available to authorized users.

Learning health systems need to bridge the ‘two cultures’ of clinical informatics and data science

“…Clinical databases only comprise patients who attended healthcare services. A UK-wide study showed the difference in asthma prevalence when asthma was reported from population surveys compared to clinical databases 10. Besides quality of coded data, there could be lack of key variables in clinical databases, since their primary purpose was not designed for research, for example, the absence of diagnoses in outpatient hospital attendances.…”

Managing problematic severe asthma: beyond the guidelines

“…More than 1 million children in the UK are diagnosed with asthma1 and direct healthcare costs associated with asthma treatment exceed £1.1 billion 2. Asthma is characterised by recurrent wheezing, breathlessness and cough, together with variable expiratory airflow limitation.…”

Beyond Climate Change and Health: Integrating Broader Environmental Change and Natural Environments for Public Health Protection and Promotion in the UK

“…The financial costs associated with asthma (excluding wider societal costs) in the UK have been estimated at £1.1 billion per year [68]. Seasonal allergies including allergic rhinitis ('hay fever') have been increasing in the UK, with some reports suggesting that as many as 40% of UK children suffer from hay fever [69]. Recent results from the "Britain Breathing" project, show that self-reported seasonal allergy symptoms across the UK are strongly correlated with reduced well-being, and these trends also correlate with the number of antihistamines prescribed by general practitioners [70].…”